Clinical Characteristics, Exercise Capacity and Pulmonary Function in Post-COVID-19 Competitive Athletes
- PMID: 34300219
- PMCID: PMC8304629
- DOI: 10.3390/jcm10143053
Clinical Characteristics, Exercise Capacity and Pulmonary Function in Post-COVID-19 Competitive Athletes
Abstract
Background: Limited evidence exists regarding adverse modifications affecting cardiovascular and pulmonary function in physical active adults affected by COVID-19, especially in athletic populations. We aimed to describe the clinical presentation of COVID-19 in a cohort of competitive athletes, as well as spirometry and echocardiography findings and cardio-respiratory performance during exercise.
Methods: Twenty-four competitive athletes with COVID-19 were recruited for this study after ending self-isolation and confirmation of negative laboratory results. All athletes underwent clinical evaluation, spirometry, echocardiography and cardiopulmonary exercise testing (CPET). These data were compared to a group of healthy control athletes.
Results: Anosmia was the most frequent symptom present in 70.83% patients, followed by myalgia, fatigue and ageusia. The most frequent persisting symptoms were anosmia 11 (45.83%) and ageusia 8 (33.33%). Compared to controls, COVID-19 patients presented lower FEV1%: 97.5 (91.5-108) vs. 109 (106-116) p = 0.007. Peak Oxygen Uptake (VO2) in COVID-19 patients was 50.1 (47.7-51.65) vs. 49 (44.2-52.6) in controls (p = 0.618).
Conclusions: Reduced exercise capacity was not identified and pulmonary and cardiovascular function are not impaired during early recovery phase in a population of physical active adults except FEV1 reduction.
Keywords: COVID-19; CPET; SARS-CoV-19; physical exercise.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19. [(accessed on 11 March 2020)];2020 Available online: https://www.who.int/director-general/speeches/detail/who-director-genera....
-
- Starekova J., Bluemke D.A., Bradham W.S., Eckhardt L.L., Grist T.M., Kusmirek J.E., Purtell C.S., Schiebler M.L., Reeder S.B. Evaluation for Myocarditis in Competitive Student Athletes Recovering from Coronavirus Disease 2019 with Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021 doi: 10.1001/jamacardio.2020.7444. - DOI - PMC - PubMed
-
- Gervasi S.F., Pengue L., Damato L., Monti R., Pradella S., Pirronti T., Bartoloni A., Epifani F., Saggese A., Cuccaro F., et al. Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection? Br. J. Sports Med. 2021;55:54–61. doi: 10.1136/bjsports-2020-102789. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous